InvestSMART

Emyria Limited (ASX:EMD)

ALERT: Price-sensitive ASX Announcement for EMD
Current share price for EMD : $0.040 -0.014 (-25.93%)+
Announcement
Release
16 Feb 2026 8:40AM
Price at Release
$0.054
Full Release
download
Summary
Emyria Limited has announced that Medibank Private Ltd will expand its funding to support Emyria's Victorian clinic at Mornington Peninsula, marking the first insurer-backed mental health program in Victoria. This initiative will aid in providing Treatment-Resistant Depression (TRD) and Post-Traumatic Stress Disorder (PTSD) programs, reducing financial barriers for patients. The clinic is expected to commence operations in the second quarter of the calendar year 2026. The expansion is supported by strong clinical evidence, with recent data showing sustained patient outcomes over 12 months. Emyria's Empax model integrates psychiatrist-led, psychotherapy-based care with robust data collection, delivered within licensed hospital environments. The collaboration with Medibank aims to make quality mental health care accessible and affordable, supporting Emyria’s national growth strategy.
Key Points
  • Medibank expands funding to support Emyria’s Victorian clinic.
  • First insurer-backed mental health programs in Victoria.
  • Operations at Mornington Peninsula clinic to commence in Q2 CY2026.
  • 12-month data confirms sustained patient outcomes.
  • Emyria’s Empax model combines psychiatrist-led care with data collection.
  • Emyria aims to make mental health care accessible to every Australian.
  • Collaboration with Medibank reduces out-of-pocket costs for patients.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.